Related Experiment Video

Updated: Jun 24, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Vaccination strategies in patients with renal cell carcinoma

Anne Marie Asemissen1, Peter Brossart

  • 1Medizinische Klinik II, Hematology and Oncolgy, St. Johannes Klinikum, An der Abtei 7-11, 47166 Duisburg, Germany. asemissen@web.de

Cancer Immunology, Immunotherapy : CII
|April 11, 2009
PubMed

Insights

Antigen-specific vaccination shows promise for advanced renal cell cancer (RCC). Combining vaccines with tyrosine kinase inhibitors may enhance T cell responses and clinical outcomes in RCC patients.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Advanced renal cell cancer (RCC) has limited treatment options.
  • Tumor-associated antigens (TAA) are being explored for RCC vaccine strategies.

Purpose of the Study:

  • To evaluate the efficacy of antigen-specific vaccination in metastatic RCC.
  • To explore novel vaccine regimes and combination therapies for improved RCC treatment.

Main Methods:

  • Utilizing dendritic cell vaccination targeting TAAs in metastatic RCC patients.
  • Developing polyvalent, HLA-independent RNA vaccines encoding multiple TAAs and adjuvants.
  • Investigating the combination of vaccines with tyrosine kinase inhibitors like sunitinib.

Main Results:

  • Antigen-specific vaccination with dendritic cells induced cytotoxic T cell responses and objective clinical responses in some metastatic RCC patients.
  • New vaccine regimes show promising clinical and immunological efficacy.
  • Sunitinib demonstrated potential to enhance T cell induction and eliminate regulatory T cells in a mouse model.

Conclusions:

  • Antigen-specific vaccination is a promising therapeutic strategy for advanced RCC.
  • Combination therapy with tyrosine kinase inhibitors may improve vaccine efficacy by modulating the immune response.
  • Further research into advanced vaccine platforms and combination strategies is warranted for RCC treatment.

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers12:22

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...